Cancer cells can acquire resistance to TRAIL-induced apoptosis through multiple mechanisms including loss of functional DR4 and DR5 at the cell surface [13], O-glycosylation status [14], and elevated expression of antiapoptotic proteins including c-FLIP [15, 16], Bcl-2 [16], or IAP family proteins [17]. This evidence concerns the gene TNFSF10 and cancer.